ENTITY

Orum Therapeutics (475830 KS)

10
Analysis
Health Care • South Korea
Orum Therapeutics, Inc. operates as a clinical stage biotech company. The Company develops cell-penetrating antibodies, biomedical therapy applications, and pharmaceuticals for cancer and immune diseases. Orum Therapeutics serves clients worldwide.
more
bullish•Enf Technology
•11 Mar 2026 05:40

KOSDAQ150 Index Rebalance Preview: Soaring AUM and Increased Flow/Impact

There could be 14 constituent changes for the KOSDAQ150 in June. AUM linked to the index has soared over the last couple of months. The forecast...

Logo
578 Views
Share
•06 Apr 2026 11:04

Primer: Orum Therapeutics (475830 KS) - Apr 2026

Orum Therapeutics is a clinical-stage biotechnology company at the forefront of developing a novel class of cancer therapeutics called...

Logo
137 Views
Share
bullish•Hyundai Movex
•30 Mar 2026 22:14

An Update on the KOSDAQ 150 Rebalance Candidates in June 2026

​Update on KOSDAQ 150 rebalance candidates in June 2026, with 8 potential addition candidates showing significant outperformance.

Logo
620 Views
Share
bullish•Alteogen Inc
•08 Jan 2026 05:30

Alteogen (196170 KS): Index Impact of KOSDAQ to KOSPI Transfer

Alteogen's shareholders have approved the KOSDAQ to KOSPI transfer. Given recent delays, the timeline could be long drawn out. KOSPI200 buying will...

Logo
665 Views
Share
bullish•SemiFive
•22 Dec 2025 19:30

An Early Look at Potential Additions and Deletions to KOSDAQ150 in June 2026

In this insight, we provide an early look at the potential additions and deletions to KOSDAQ 150 rebalance in June 2026. Of the eight potential...

Logo
2.1k Views
Share
x